AAV Immunogenicity: New Answers Create New Questions
| dc.contributor.author | Shirley, Jamie L. | |
| dc.contributor.author | Herzog, Roland W. | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2020-01-03T19:56:36Z | |
| dc.date.available | 2020-01-03T19:56:36Z | |
| dc.date.issued | 2018-11-07 | |
| dc.description.abstract | Comment on Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. [J Clin Invest. 2018] | en_US |
| dc.identifier.citation | Shirley, J. L., & Herzog, R. W. (2018). AAV Immunogenicity: New Answers Create New Questions. Molecular therapy : the journal of the American Society of Gene Therapy, 26(11), 2538–2539. doi:10.1016/j.ymthe.2018.10.004 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/21726 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.ymthe.2018.10.004 | en_US |
| dc.relation.journal | Molecular Therapy | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Capsid | en_US |
| dc.subject | Capsid proteins | en_US |
| dc.subject | Dependovirus | en_US |
| dc.subject | Humans | en_US |
| dc.title | AAV Immunogenicity: New Answers Create New Questions | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225012/ | en_US |